Aundrietta Duncan

Aundrietta Duncan

Company: Salarius Pharmaceuticals

Job title: Director, Non-Clinical Development


Targeting FET-Rearranged Sarcomas Through Inhibition of LSD1 3:30 pm

Understanding the scaffolding function of LSD1 Highlighting the seclidemstat mediated inhibition of LSD1 proteinprotein interactions Evaluating the in vitro activity of seclidemstat in FET-rearranged sarcomasRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.